This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Simcere Pharmaceutical Co., Ltd., Simcere Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 3 Years Active: 2026
Title: Innovations in Stroke Treatment by Xiaofei Feng
Introduction
Xiaofei Feng is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicine, particularly in the treatment of cerebral strokes. His innovative approach combines established compounds to enhance patient outcomes.
Latest Patents
Xiaofei Feng holds a patent for the "Use of composition in treatment of cerebral stroke." This patent details a composition that includes edaravone and dexborneol, specifically designed for treating patients with a history of hypertension suffering from cerebral strokes. This innovative treatment method aims to improve recovery and reduce complications associated with strokes.
Career Highlights
Throughout his career, Xiaofei Feng has worked with prominent companies in the pharmaceutical industry. He has been associated with Simcere Pharmaceutical Co., Ltd. and Jiangsu Simcere Pharmaceutical Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and treatment strategies.
Collaborations
Xiaofei Feng has collaborated with several professionals in his field, including Shunwei Zhu and Cuncun Liu. These collaborations have contributed to the advancement of his research and the successful development of his patented treatment methods.
Conclusion
Xiaofei Feng's contributions to stroke treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the pharmaceutical industry and offers hope for better treatment options for stroke patients.